Immunotherapy to CD5, a T-cell antigen having roles from development to peripheral function: Future prospective and...

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• CD5 is a key pan T-cell marker involved in T-cell development, activation, and tolerance.
• Its expression levels vary and are associated with diverse immunological conditions and diseases.
• CD5 exists in membrane (mCD5), intracellular (cCD5), and soluble (sCD5) forms.

Purpose of the Study:

• To explore the multifaceted roles of CD5 in immune regulation.
• To investigate the significance of altered CD5 expression in various disease states.
• To elucidate the origins and implications of different CD5 isoforms, particularly cCD5.

Main Methods:

• Analysis of CD5 expression patterns in different T-cell subsets and disease conditions.
• Investigation of mRNA variants (E1A, E1B) responsible for generating mCD5 and cCD5.
• Exploration of the regulatory mechanisms influencing cCD5 expression.

Main Results:

• CD5 expression levels correlate with T-cell selection, competency, and effector function.
• Aberrant CD5 expression is observed in conditions like solid tumors, anergy, leukemia, and autoimmunity.
• Intracellular CD5 (cCD5) is generated from a non-conventional mRNA variant (E1B), influenced by factors like leukemia and hypoxia.

Conclusions:

• CD5's diverse roles and altered expression patterns highlight its importance in immune homeostasis and disease.
• Understanding the distinct CD5 isoforms, especially cCD5 derived from the E1B variant, provides insights into leukemogenesis.
• Targeting mCD5 with monoclonal antibodies (mAbs) shows promise for restoring immune responses in cancer, while cCD5 offers novel immunotherapy avenues.